Annexin A5 in Patients With Severe COVID-19 Disease: A Single Centre, Randomized, Double-blind, Placebo-controlled Pilot Trial
Randomized, double-blind, placebo-controlled trial comparing 2 doses of SY-005 (recombinant human Annexin A5) to placebo in patients with severe coronavirus 2019 disease in a single hospital centre with 2 intensive care units
100 项与 Ontario Ministry of Colleges and Universities 相关的临床结果
0 项与 Ontario Ministry of Colleges and Universities 相关的专利(医药)
100 项与 Ontario Ministry of Colleges and Universities 相关的药物交易
100 项与 Ontario Ministry of Colleges and Universities 相关的转化医学